🔎 Trials Near Me

Akèy › Menenjyom › Florid › Miami

Etid klinik pou Menenjyom nan Miami, FL

7 etid pou Menenjyom ap chèche patisipan nan sit nan ak bò kote Miami (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

Ap rekriteFaz 2
  • University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT02523014

Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment

Ap rekriteFaz 2
  • University of Miami, Miami
  • Baptist Health Medical Group Oncology, Miami
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06955169

A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma

Ap rekriteFaz 2
  • Baptist Health Miami Cancer Institute, Miami
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT07428616

Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)

Ap rekriteFaz 2
  • University of Miami, Miami
Laj 12 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT04374305

Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)

Ap rekriteEtid obsèvasyon
  • Miami Cancer Institute, Baptist Health South Florida, Miami
Tout laj · Tout sèks · Mizajou Jul 22, 2026 · NCT04427384

Cabozantinib for Patients With Recurrent or Progressive Meningioma

Ap rekriteFaz 2
  • Miami Cancer Institute at Baptist Health, Inc., Miami
Laj 18 ak plis · Tout sèks · Mizajou May 14, 2026 · NCT05425004

Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors

Ap rekriteFaz 1/2
  • Biogenix Molecular, Miami
Laj 18 a 90 · Tout sèks · Mizajou May 14, 2026 · NCT05636618

Etid Menenjyom nan lòt vil

Lòt etid nan Miami

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.